A kidney biopsy in Israel typically costs from $3,500 to $5,800. The final price depends on the biopsy method, such as percutaneous needle or surgical procedures. Patients in the US usually pay about $9,000 for similar diagnostics. Israel provides localized savings of about 48% compared to US averages. Most prices cover the procedure and initial evaluation over three working days.
Bookimed Expert Insight: Choosing a multidisciplinary center offers high value for complex kidney cases. Facilities like Sheba Medical Center utilize specialized units for endourology and kidney stones. These departments provide access to pioneers in kidney-sparing surgery and advanced diagnostic protocols. Sourasky Medical Center treats over 1,800,000 patients annually and maintains a high oncology success rate. Patients benefit from specialists who also lead international uro-oncology research boards. This level of expertise is critical for accurate biopsy interpretation and follow-up care.
| Israel | Turkey | Austria | |
| Kidney biopsy | from $3,500 | from $400 | from $1,450 |
No hidden fees – just official clinic prices. Pay at the clinic for Kidney biopsy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Kidney biopsy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Kidney biopsy journey.
Dr. Barak Rosenzweig, MD, directs the Urological Oncology Service at Sheba Medical Center. He is a uro-oncologic surgeon with nearly 20 years of experience. He treats complex urologic cancers with advanced robotic and minimally invasive methods. He is listed among Israel’s Best Doctors by Forbes.
Expertise includes tumors of the prostate, kidney, bladder, testis, and upper urinary tract. He performs robotic radical prostatectomy, kidney-sparing partial nephrectomy, and advanced laparoscopy. Diagnostics include MRI-guided fusion biopsy and imaging-based personalized planning.
He completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a Senior Physician in the Department of Urology and a Clinical Senior Lecturer at Tel Aviv University. He is a graduate of the Sheba Talpiot program. He is an active researcher with over 200 publications in urologic oncology.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
Dr. Jack Baniel is the Chief of Urology at Rabin Medical Center. He specializes in bladder reconstruction and nerve-preserving cancer surgeries. He founded the oncourological department at Beilinson Hospital. Dr. Baniel is a Professor of Urology with over 100 published scientific articles.
The doctor is a board-certified surgeon with extensive experience in minimally invasive and robotic surgery. Specializing in these advanced surgical techniques, the doctor practices at Sourasky Medical Center, where they apply their expertise to improve patient outcomes.